ALERE INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-12-03: Form 8-K; Period of report 2014-12-01; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
- 2014-10-28: Form 8-K; Period of report 2014-10-28; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2014-10-28: Form 8-K; Period of report 2014-10-25; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2014-10-28: Form 8-K; Period of report 2014-10-27; Description 1.01 Entry into a Material Definitive Agreement; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2014-12-03 | 8-K | 2014-12-01 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | d831422d8k.htm |
| 2014-10-28 | 8-K | 2014-10-28 | 2.02 Results of Operations and Financial Condition | 2.02 On October 28, 2014, Alere Inc. (the “Company”) issued a press release entitled “Alere Inc. Announces Third Quarter 2014 Results,” a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1. | d812428d8k.htm |
| 2014-10-28 | 8-K | 2014-10-25 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 25, 2014, the board of directors of Alere Inc. (the “Company”) elected Namal Nawana as the Company’s Chief Executive Officer and President, removing the interim status previously assigned to his service in those roles. | d812368d8k.htm |
| 2014-10-28 | 8-K | 2014-10-27 | 1.01 Entry into a Material Definitive Agreement | 1.01 On October 27, 2014, Alere Inc. (“Alere”) and Alere Health, LLC, a wholly owned subsidiary of Alere (“Alere Health”), entered into a membership interest purchase agreement (the “Purchase Agreement”) with Optum, pursuant to which Alere agreed to sell Alere Health and its subsidiaries, which together comprise Alere’s condition management, case management, wellbeing, wellness, and women’s and children’s health businesses (collectively, the “Health Management Business”), to Optum for a purchase price of $600.0 million. | d810023d8k.htm |
| 2014-10-17 | 8-K | 2014-10-10 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On October 10, 2014, Alere Inc. (“Alere” or the “Company”) completed the sale of its subsidiary Alere Accountable Care Solutions, LLC (“ACS”) to ACS Acquisition, LLC (the “Purchaser”), pursuant to the terms of a Membership Interest Purchase Agreement among Alere, Alere Health Improvement Company, ACS and Sumit Nagpal. | d806518d8k.htm |
| 2014-09-16 | 8-K | 2014-09-15 | 7.01 Regulation FD Disclosure | 7.01 On September 15, 2014, we issued a press release entitled “Alere Responds to Letter from Former Executives.” The press release was issued in response to a letter from our former chief executive officer, Ron Zwanziger, and two other former executive officers. | d790169d8k.htm |
| 2014-09-04 | 8-K | 2014-08-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 As of August 31, 2014, our Compensation Committee awarded retention-based restricted stock units (RSU’s) to a number of executives and key employees, including David Teitel, our Chief Financial Officer. | d784083d8k.htm |
| 2014-08-26 | 8-K | 2014-08-21 | 3.03 Material Modification to Rights of Security Holders; 5.07 Submission of Matters to a Vote of Security Holders | 3.03 On August 25, 2014, Alere Inc. (the “Company”) filed a Fifth Amendment (the “Fifth Amendment”) to the Amended and Restated Certificate of Incorporation of the Company (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware. 5.07 The Company held its 2014 Annual Meeting of Stockholders (“2014 Annual Meeting”) on August 21, 2014. | d780133d8k.htm |
| 2014-08-04 | 8-K | 2014-08-04 | 2.02 Results of Operations and Financial Condition | 2.02 On August 4, 2014, Alere Inc. (the “Company”) issued a press release entitled “Alere Inc. Announces Second Quarter 2014 Results,” a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1. | d768380d8k.htm |
| 2014-07-07 | 8-K | 2014-07-07 | 7.01 Regulation FD Disclosure | 7.01 On July 7, 2014, Gregg J. Powers, the Chairman of our Board of Directors, and Namal Nawana, our Interim Chief Executive Officer, Interim President and Chief Operating Officer, issued the messages to our stockholders which are furnished with this Current Report on Form 8-K as Exhibits 99.1 and 99.2 and incorporated by reference herein. | d753353d8k.htm |
| 2014-07-01 | 8-K | 2014-06-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 On July 1, 2014, our board of directors announced changes to the senior leadership of our company. 8.01 On July 1, 2014, we issued a press release entitled “Alere Announces Management Transition,” which is attached hereto as Exhibit 99.1. | d752747d8k.htm |
| 2014-06-05 | 8-K | 2014-05-30 | 1.01 Entry into a Material Definitive Agreement; 5.07 Submission of Matters to a Vote of Security Holders | 1.01 Entry into a Material Definitive Agreement. 5.07 The consent solicitations relating to the Notes described in Item 1.01 above expired at 5:00 p.m. | d739573d8k.htm |
| 2014-05-21 | 8-K | 2014-05-21 | 7.01 Regulation FD Disclosure; 8.01 Other Events | 7.01 In connection with the solicitation by Alere Inc. (the “Company”) of consents from the holders of its outstanding 7.250% Senior Notes due 2018, its 8.625% Senior Subordinated Notes due 2018 and its 6.500% Senior Subordinated Notes due 2020 that will, among other things, permit the Company to proceed with its previously announced transaction involving BBI Diagnostics Group Plc (“BBI Diagnostics”), the Company is making available the following information. 8.01 On May 21, 2014, the Company issued a press release announcing that it has commenced a consent solicitation to waive and amend certain provisions of the indentures relating to its 7.250% Senior Notes due 2018, its 8.625% Senior Subordinated Notes due 2018 and its 6.500% Senior Subordinated Notes due 2020. | d732329d8k.htm |
| 2014-05-05 | 8-K | 2014-05-05 | 8.01 Other Events | 8.01 On May 5, 2014, the Company issued a press release entitled “Alere Announces Separation of Chief Executive Officer and Chairman Roles and Review of Strategy,” a copy of which is filed with this Current Report on Form 8-K as Exhibit 99.1 and incorporated by reference herein. | d723488d8k.htm |
| 2014-04-29 | 8-K | 2014-04-29 | 2.02 Results of Operations and Financial Condition; 8.01 Other Events | 2.02 On April 29, 2014, Alere Inc. (the “Company”) issued a press release entitled “Alere Inc. Announces First Quarter 2014 Results,” a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1 and incorporated by reference herein. 8.01 On April 29, 2014, the Company issued a press release entitled “Alere Inc. Announces Plan For Initial Public Offering By BBI Diagnostics Group PLC,” a copy of which is filed with this Current Report on Form 8-K as Exhibit 99.2 and incorporated by reference herein. | d716350d8k.htm |
| 2014-02-06 | 8-K | 2014-02-06 | 2.02 Results of Operations and Financial Condition | 2.02 On February 6, 2014, Alere Inc. (the “Company”) issued a press release entitled “Alere Inc. Announces Fourth Quarter 2013 Results,” a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1. | d671721d8k.htm |